Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip van den Bosch

Showing results (11-20 of 192) with videos related to

Pageof 20
Sort By:
Current Opinion in Rheumatology|May 24, 2012
Peripheral manifestations in spondyloarthritis: relevance for diagnosis, classification and follow-upPhilippe Carron, Liesbet Van Praet, Filip Van den Bosch
Current Opinion in Rheumatology|June 10, 2006
Clinical assessment in the spondyloarthropathies, including psoriatic arthritisFilip Van den Bosch, Bert Vander Cryssen, Herman Mielants
RMD Open|May 10, 2020
Peripheral spondyloarthritis: a neglected entity-state of the artPhilippe Carron, Ann-Sophie De Craemer, Filip Van den Bosch
Current Rheumatology Reports|May 28, 2005
Gut inflammation in the spondyloarthropathiesHerman Mielants, Filip De Keyser, Dominique Baeten, et al.
Nature Reviews. Rheumatology|April 18, 2012
The transition of acute to chronic bowel inflammation in spondyloarthritisLiesbet Van Praet, Peggy Jacques, Filip Van den Bosch, et al.
Current Rheumatology Reports|July 12, 2011
Mucosal inflammation in spondylarthritides: past, present, and futureLiesbet Van Praet, Filip Van den Bosch, Herman Mielants, et al.
Clinical and Experimental Rheumatology|September 24, 2024
Fourteenth International Congress on SpondyloarthritidesMaria Antonietta D'Agostino, Nigel Haroon, Dirk Elewaut, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2015
Reply: To PMID 25545240Philip Mease, Joachim Sieper, Filip Van den Bosch, et al.
Arthritis Research & Therapy|June 18, 2010
Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapyMartin Rudwaleit, Filip Van den Bosch, Martina Kron, et al.
Arthritis Research & Therapy|May 19, 2005
Tumor necrosis factor-alpha blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?Filip Van den Bosch, Filip De Keyser, Herman Mielants, et al.
Pageof 20

Showing results (11-20 of 192) with videos related to

Sort By:
Pageof 20
Current Opinion in Rheumatology|May 24, 2012
Peripheral manifestations in spondyloarthritis: relevance for diagnosis, classification and follow-upPhilippe Carron, Liesbet Van Praet, Filip Van den Bosch
Current Opinion in Rheumatology|June 10, 2006
Clinical assessment in the spondyloarthropathies, including psoriatic arthritisFilip Van den Bosch, Bert Vander Cryssen, Herman Mielants
RMD Open|May 10, 2020
Peripheral spondyloarthritis: a neglected entity-state of the artPhilippe Carron, Ann-Sophie De Craemer, Filip Van den Bosch
Current Rheumatology Reports|May 28, 2005
Gut inflammation in the spondyloarthropathiesHerman Mielants, Filip De Keyser, Dominique Baeten, et al.
Nature Reviews. Rheumatology|April 18, 2012
The transition of acute to chronic bowel inflammation in spondyloarthritisLiesbet Van Praet, Peggy Jacques, Filip Van den Bosch, et al.
Current Rheumatology Reports|July 12, 2011
Mucosal inflammation in spondylarthritides: past, present, and futureLiesbet Van Praet, Filip Van den Bosch, Herman Mielants, et al.
Clinical and Experimental Rheumatology|September 24, 2024
Fourteenth International Congress on SpondyloarthritidesMaria Antonietta D'Agostino, Nigel Haroon, Dirk Elewaut, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2015
Reply: To PMID 25545240Philip Mease, Joachim Sieper, Filip Van den Bosch, et al.
Arthritis Research & Therapy|June 18, 2010
Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapyMartin Rudwaleit, Filip Van den Bosch, Martina Kron, et al.
Arthritis Research & Therapy|May 19, 2005
Tumor necrosis factor-alpha blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?Filip Van den Bosch, Filip De Keyser, Herman Mielants, et al.
Pageof 20